Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.
Carr L., Norris K., Parker H., Nilsson-Takeuchi A., Bryant D., Amarasinghe H., Kadalayil L., Else M., Pettitt A., Hillmen P., Schuh A., Walewska R., Baird DM., Oscier DG., Oakes CC., Gibson J., Pepper C., Strefford JC.